Yes long post! But just a piece from article out of investors meeting!
$Movano(MOVE.US$ This is why im bullish! This is why im swinging this! ( longer term than most of my swing ) This is why i will continue adding at these prices! NFA! Always use you cost positioning that your trading plan states! Do your DD! And as always GL & big profits to ya![]()
(((((. Key Takeaways
• Movano Health's Evie Ring launch surpassed expectations, with a waitlist of over 8,000 potential buyers.
• The company closed a $24 million private placement, bolstered by a $3 million strategic investment from a top-tier medical device company.
• Focus on achieving FDA clearance for pulse rate and blood oxygen monitoring, launching Evie Med, and exploring B2B markets.
• Successful clinical trial for wearable blood pressure monitoring device, meeting FDA accuracy criteria.
• Plans to expand product offerings beyond the Evie Ring and Evie Med, targeting noninvasive blood glucose monitoring for diabetes patients.
• Operating loss of $6 million for Q4 2023, with $6.1 million in cash and cash equivalents as of December 31, 2023.
• Intent to connect future products with Apple (NASDAQ:AAPL) Health and explore various form factors and measurement sites for blood pressure and glucose monitoring.
Company Outlook
• Movano Health aims to achieve FDA clearance for additional health monitoring features and launch Evie Med.
• The company is targeting B2B opportunities in clinical trials, payer, and remote patient monitoring markets.
• Expansion plans include multi-analyte sensing and additional FDA clearances.
Bearish Highlights
• Movano Health faced capital constraints and operational challenges, impacting volume production.
• The company reported a $6 million operating loss for the fourth quarter of 2023.
Bullish Highlights
• Strategic investment from a Tier 1 medical device company demonstrates confidence in Movano Health's technology.
• Successful clinical trial for blood pressure monitoring device, with potential for inclusion in the Evie product suite.
Misses
• Despite the successful launch, production volume was limited due to earlier capital and operational hurdles.
Q&A Highlights
• Movano Health is considering various form factors for its products, including rings, bands, and potentially finger-based blood pressure monitoring.
• The company is flexible in its approach to noninvasive glucose monitoring, exploring different measurement sites.
• There is an intention to integrate future products with platforms like Apple Health for a more connected health experience.
Movano Health's earnings call painted a picture of a company at the cusp of significant growth, with a clear strategy to overcome its initial production challenges and capitalize on the success of its Evie Ring. With a strong financial backing and a robust product pipeline, Movano Health is poised to make a notable impact in the wearable health technology market.
• Movano Health's Evie Ring launch surpassed expectations, with a waitlist of over 8,000 potential buyers.
• The company closed a $24 million private placement, bolstered by a $3 million strategic investment from a top-tier medical device company.
• Focus on achieving FDA clearance for pulse rate and blood oxygen monitoring, launching Evie Med, and exploring B2B markets.
• Successful clinical trial for wearable blood pressure monitoring device, meeting FDA accuracy criteria.
• Plans to expand product offerings beyond the Evie Ring and Evie Med, targeting noninvasive blood glucose monitoring for diabetes patients.
• Operating loss of $6 million for Q4 2023, with $6.1 million in cash and cash equivalents as of December 31, 2023.
• Intent to connect future products with Apple (NASDAQ:AAPL) Health and explore various form factors and measurement sites for blood pressure and glucose monitoring.
Company Outlook
• Movano Health aims to achieve FDA clearance for additional health monitoring features and launch Evie Med.
• The company is targeting B2B opportunities in clinical trials, payer, and remote patient monitoring markets.
• Expansion plans include multi-analyte sensing and additional FDA clearances.
Bearish Highlights
• Movano Health faced capital constraints and operational challenges, impacting volume production.
• The company reported a $6 million operating loss for the fourth quarter of 2023.
Bullish Highlights
• Strategic investment from a Tier 1 medical device company demonstrates confidence in Movano Health's technology.
• Successful clinical trial for blood pressure monitoring device, with potential for inclusion in the Evie product suite.
Misses
• Despite the successful launch, production volume was limited due to earlier capital and operational hurdles.
Q&A Highlights
• Movano Health is considering various form factors for its products, including rings, bands, and potentially finger-based blood pressure monitoring.
• The company is flexible in its approach to noninvasive glucose monitoring, exploring different measurement sites.
• There is an intention to integrate future products with platforms like Apple Health for a more connected health experience.
Movano Health's earnings call painted a picture of a company at the cusp of significant growth, with a clear strategy to overcome its initial production challenges and capitalize on the success of its Evie Ring. With a strong financial backing and a robust product pipeline, Movano Health is poised to make a notable impact in the wearable health technology market.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Seraphicall : This looks good
TrytosaveabitOP Seraphicall: I really like what I’ve been seeing! That’s why I’m actually planning a longer swing trade than I would normally do!
taijahmed75 TrytosaveabitOP: wow, it’s an amazing work you have done. Thank you
TrytosaveabitOP taijahmed75: Thank you! And you’re very welcome! GL
Stock_Drift : You’re in good shape. Nice swing!!!
TrytosaveabitOP Stock_Drift: Sweet!
Ben Buttons : Take us to the promise land....lol
TrytosaveabitOP Ben Buttons: Yes! Sign me up for that ride! Hehehe!